As of 2025-11-02, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (33.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -2284.0%.
The range of the Relative Valuation is (26.99) - (37.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 17.3x | 15.5x |
| Forward P/E multiples | 12.2x - 18.8x | 15.4x |
| Fair Price | (26.99) - (37.57) | (33.63) |
| Upside | -1852.8% - -2539.8% | -2284.0% |
| Date | P/E |
| 2025-10-29 | -0.73 |
| 2025-10-28 | -0.71 |
| 2025-10-27 | -0.78 |
| 2025-10-24 | -0.80 |
| 2025-10-23 | -0.80 |
| 2025-10-22 | -0.74 |
| 2025-10-21 | -0.75 |
| 2025-10-20 | -0.76 |
| 2025-10-17 | -0.69 |
| 2025-10-16 | -0.76 |
| 2025-10-15 | -0.76 |
| 2025-10-14 | -0.78 |
| 2025-10-13 | -0.85 |
| 2025-10-10 | -0.75 |
| 2025-10-09 | -0.89 |
| 2025-10-08 | -0.90 |
| 2025-10-07 | -0.84 |
| 2025-10-06 | -0.97 |
| 2025-10-03 | -1.00 |
| 2025-10-02 | -0.88 |
| 2025-10-01 | -0.83 |
| 2025-09-30 | -0.84 |
| 2025-09-29 | -0.80 |
| 2025-09-26 | -0.86 |
| 2025-09-25 | -0.82 |
| 2025-09-24 | -0.71 |
| 2025-09-23 | -0.58 |
| 2025-09-22 | -0.58 |
| 2025-09-19 | -0.56 |
| 2025-09-18 | -0.50 |
| 2025-09-17 | -0.48 |
| 2025-09-16 | -0.50 |
| 2025-09-15 | -0.48 |
| 2025-09-12 | -0.49 |
| 2025-09-11 | -0.54 |
| 2025-09-10 | -0.54 |
| 2025-09-09 | -0.50 |
| 2025-09-08 | -0.51 |
| 2025-09-05 | -0.56 |
| 2025-09-04 | -0.50 |
| 2025-09-03 | -0.47 |
| 2025-09-02 | -0.47 |
| 2025-08-29 | -0.54 |
| 2025-08-28 | -0.52 |
| 2025-08-27 | -0.55 |
| 2025-08-26 | -0.51 |
| 2025-08-25 | -0.51 |
| 2025-08-22 | -0.54 |
| 2025-08-21 | -0.47 |
| 2025-08-20 | -0.38 |